Zimmer Partners LP Purchases New Position in Kestra Medical Technologies, Ltd. $KMTS

Zimmer Partners LP purchased a new stake in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) in the first quarter, Holdings Channel.com reports. The institutional investor purchased 15,000 shares of the company’s stock, valued at approximately $374,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in KMTS. T. Rowe Price Investment Management Inc. acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $56,613,000. Omega Fund Management LLC acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $44,754,000. Alliancebernstein L.P. acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $29,500,000. Brown Advisory Inc. acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $13,716,000. Finally, Millennium Management LLC purchased a new stake in Kestra Medical Technologies in the first quarter valued at approximately $11,036,000.

Kestra Medical Technologies Trading Up 0.1%

Shares of NASDAQ KMTS opened at $17.87 on Wednesday. The company has a debt-to-equity ratio of 0.20, a current ratio of 6.72 and a quick ratio of 6.72. Kestra Medical Technologies, Ltd. has a twelve month low of $13.25 and a twelve month high of $26.15. The company has a 50 day moving average price of $16.22.

Analyst Ratings Changes

Separately, Wells Fargo & Company reduced their price objective on Kestra Medical Technologies from $28.00 to $27.00 and set an “overweight” rating for the company in a research note on Thursday, July 17th. Five equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Kestra Medical Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $27.33.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.